Develops cancer drug candidates and proton therapy systems for treating cancers.
10-K for FY2025, filed Mar 31, 2026
$200K
10-K, filed Mar 28, 2016
$200K ↗No. It lost $2.9M in FY2015.
10-Q for Q2 FY2026, filed Aug 14, 2026
−$2.3MView ↗
8-K, filed Jul 2, 2026
On July 1, 2026, the Merger was consummated by the filing of a Certificate of Merger filed with the Secretary of State of the State of…View ↗
Added proton therapy
The older report describes drug discovery focused on protein phosphatase inhibitors; the latest adds Liora’s electronically controlled proton therapy systems alongside cancer drug development.
10-K for FY2022, filed Mar 29, 2023 10-K for FY2025, filed Mar 31, 2026
Loading...